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Abstract - An efficient and generalized photochemical methodology for the 
preparation of fluorinated quinazolin-4-ones is described. Depending on the 
starting substrate, quinazolin-4-ones bearing a perfluoroalkyl- or perfluoroaryl- 
substituent in position 2 or fluorine atoms on any positions of the benzo-fused 
moiety can easily be obtained. 5-Aryl-3-perfluoroalkylpentafluorophenyl- or 5-
polyfluoroaryl-3-phenyl(methyl)-1,2,4-oxadiazoles, respectively, can be 
considered as ideal precursors that can be transformed into the target quinazolin-
4-ones by irradiation in the presence of triethylamine (TEA) (at λ = 313 nm) or 
pyrene (at λ = 365 nm)  in dry methanol or acetonitrile as solvent. Some 
mechanistic considerations confirm the involvement of a photoinduced electron 
transfer process. 
  
INTRODUCTION 
 
Fluorinated heterocycles are interesting compounds widely used in medicinal, agricultural and polymer 
chemistry, and their synthesis represents a research area of growing interest.1 Although the direct 
introduction of fluorine or perfluoroalkyl groups into heterocyclic structures can be realized by using 
fluorinating or perfluoroalkylating reagents, a widely used approach to fluorinated heterocycles includes 
building-block strategies, which achieve the formation of the heterocyclic ring from fluorinated 
precursors.1 In this context, a promising strategy uses the photoinduced rearrangements of O-N bond 
containing azoles such as furazans and 1,2,4-oxadiazoles.2  In the field of photochemical strategies for the 
synthesis of heterocyclic compounds, an interesting reactivity of the 1,2,4-oxadiazole heterocycle is 
represented by the photochemical transformation of the 5-aryl-1,2,4-oxadiazole system into quinazolin-4-
ones derivatives.3,4 This process, which takes place under irradiation of the oxadiazoles in the presence of 
sensitizers or triethylamine (TEA), involves a photoinduced electron transfer between the excited 
sensitizer (S) (donor) and the ground state oxadiazole (OXA) (acceptor) or between the excited 
oxadiazole (acceptor) and the TEA (donor), followed by cyclization of the open-chain radical anion 
intermediate into the final quinazolin-4-one product (Scheme 1).  
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In the frame of our research5,6 on the synthesis of fluorinated heterocycles, we became interested in how 
this photoinduced process could have been applied as a general methodology for the synthesis of 
fluorinated quinazolin-4-ones. Our interest towards this class of compounds comes from the fact that 
quinazolin-4-ones are associated with a wide range of pharmaceutical properties and are used as analgesic 
and antiinflammarory,7 antimicrobial,8 antiparkinson,9 and affect the central nervous system.10 They 
recently have been also tested as anticancer drugs,11 as anticonvulsant agents,12,13 and as neuropeptide Y 
receptor antagonists for the treatment of obesity and circulatory disorders.14 Moreover, all these 
properties can, in principle, be strongly affected by the presence of a fluorinated moiety. 
To better introduce this work, we needed to recall that a general synthesis of the quinazolin-4-one system 
exploits the use of anthranilic acid fused with aliphatic amines or nitriles, in one hand, or the use of        
o-aminobenzamides reacted with acylating reagents. For the synthesis of 2-perfluoroalkyl derivatives, 
examples of the last procedure are reported together with the use of 2-aminobenzonitrile (as a precursor) 
reacted with perfluoroalkanoyl chloride followed by cyclization in basic medium.15 As for our approach, 
we programmed the synthesis of quinazolin-4-ones bearing a fluorinated group (perfluoroalkyl- or 
perfluoroaryl-) at the C(2), starting from 5-aryl-1,2,4-oxadiazoles bearing the fluorinated group at the 
C(3). On the other hand, quinazolin-4-ones derivatives polyfluorosubstituted at the benzo-fused moiety 
can be obtained from the appropriate 5-polyfluoroaryl-1,2,4-oxadiazoles. The latter approach is an 
interesting because it allows the synthesis of fluorinated quinazolin-4-ones difficoult to obtain through the 
above cited conventional methodologies. 
 
RESULTS AND DISCUSSION 
 
To realize our project, we considered two series of 1,2,4-oxadiazoles: componds (5a-d) and compounds 
(5e-h) (Scheme 2). Referring to our previous results on the sensitized photorearrangement of 1,2,4-
oxadiazoles, we performed irradiations in the presence of TEA (at λ = 313 nm) or in the presence of 
pyrene (at λ = 365 nm). 
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a: W,X,Y,Z = H; R’ = CF3  e: W,X,Y,Z = F; R’ = Ph 
b: W,X,Y,Z = H; R’ = C3F7  f: W,X,Y = F; Z = H; R’ = Ph 
c: W,X,Y,Z = H; R’ = C7F15  g: W,X,Y,Z = F; R’ = Me 
d: W,X,Y,Z = H; R’ = C6F5  h: W,X,Y, = F; Z = H; R’ = Me 
 
3-Perfluoaroalkyloxadiazoles (5a-c) were prepared by an isoheterocyclic rearrangement reaction of the 
corresponding 5-perfluoroalkyl-3-phenyl-1,2,4-oxadiazoles with hydroxylamine in DMF.6 In turn, the 3-
pentafluorophenyl derivative (5d) was obtained by the conventional procedure exploiting the reaction of 
the pentafluorobenzamidoxime with benzoyl chloride.16 Similarly, the 5-polyfluorophenyloxadiazoles 
(5e-h) were prepared from acetamidoxime or benzamidoxime with the appropriate polyfluorobenzoyl 
chloride in anhydrous toluene at reflux.17  
All the photochemical reactions were performed on a preparative scale (~ 0.5 g of substrate) and were 
followed by chromatographic separation of the reaction mixture, where minor byproducts (< 5 %) were 
discarded. 
 
Irradiations at λ= 313 nm in the presence of TEA 
 
Considering our previous results on unfluorinated 5-aryl-1,2,4-oxadiazoles,3,4 we performed a series of 
irradiations of compounds (5a-h) at λ = 313 nm in the presence of TEA and using acetonitrile as solvent. 
Results are reported in Table 1. The use of methanol as irradiation solvent was avoided because, in the 
case of compounds (5a-c), irradiations in methanol/TEA resulted in decomposition of the intermediates, 
while for compounds (5d-g) the use of methanol causes the base–induced displacement of the 4-fluoro 
moiety of the aryl system with the nucleophilic solvent.5b The yields are acceptable for compounds     
(6d-h), however, compounds (6a-c) were obtained in low yields even after a longer irradiation. The lower 
reactivity shown by compound (5a-c) could be ascribed to the very low absorbance of the substrate at the 
irradiation wavelength: unfortunately, alternative irradiations at λ= 254 nm were not feasible due to 
competing reactions of the oxadiazole substrate and photodegradation of the just formed quinazolin-4-one. 
 
Irradiations at λ= 365 nm in the presence of pyrene 
 
We then decided to improve our procedure trying pyrene as a sensitizer with the advantage of irradiating 
at a wavelength where both the substrate and the final product do not absorb, thus minimizing 
photodecomposition processes. 
 
Table 1. - Yields of quinazolin-4-ones (6a-h) from irradiations of oxadiazoles (5a-h) 
Irradiation with TEAa    Irradiation with pyreneb 
Compd Yield (%) Recovered  Yield (%) Recovered 
             Starting Material             Starting Material 
___________________________________________________________________________________________ 
6a  5  68 c   75 d  5 
6b  5  70 c    40 d  25    
6c  16  80 c    45 d  35    
6d  21  69   56  25    
6e  45  40   35  51    
6f  35  57   35  53    
6g  55  20   37  51    
6h  60  10   41  54 
_____________________________________________________________________________________ 
a
 Irradiation time 2 h; 
b
 Irradiation time 5 h; 
c 
Irradiation time 4 h; 
d Irradiation performed in methanol. 
As shown in Table 1, irradiations of compounds (5a-h) in acetonitrile and in the presence of pyrene lead 
to the formation of quinazolin-4-ones (6a-h) in reasonable to good yields. [Actually, for compounds     
(5a-c) irradiations in methanol gave better results than those performed in acetonitrile where 5-10% 
yields were obtained toghether with substantial amount of unidentified decomposition byproducts]. On a 
separate experiment, the quinazolin-4-ones showed to be unstable under the irradiation conditions, for 
this reason we decided to stop the irradiation of the substrate before its complete conversion; 
chromatographic separation allowed to isolate the product and to recycle the unreacted starting material. 
It is noteworthy that this photochemical methodology allows an easy preparation of  5,6,7,8-tetrafluoro- 
and 5,6,7-trifluoroquinazolin-4-ones (6e-h) otherwise difficult to prepare by conventional procedure 
which should have employed polyfluoro-substituted 2-aminobenzamides (or nitriles), or polyfluoro-
substituted anthranilic acid. It is interesting that, in the case of the 5-pentafluorophenyloxadiazole (7), the 
irradiation resulted in the formation of the reduction product (9) only; the corresponding quinazolin-4-one 
(6d) is not observed, likely because of the uneasy displacement of the 2-fluoro substituent on the aromatic 
ring during the cyclization step of the radical anion intermediate (8) (Scheme 3). Finally, considering the 
double nature of the pyrene as an electron-transfer and/or energy transfer sensitizer, we analized the 
singlet energies (from fluorescence emission spectra) of oxadiazoles (5a-h); data shown in Table 2 clearly 
rule out any involvement of a singlet energy transfer process between the excited pyrene (ES = 322         
kJ mol-1)18 and the ground state oxadiazole (with energy values of the excited state all ranging between        
ES = 408-431 kJ mol-1) and this supports the hypothesis of a photoinduced electron transfer involved in 
the photoreaction mechanism and is in agreement with what previously reported for the unfluorinated 
analogues.3 
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Table 2. – UV absorption (λmax) and energy values  of the  
singlet excited state (Es) of compounds (5a-h) as determined  
from fluorescence emission spectra in methanol 
________________________________________________ 
Compound  λmax (nm)  Es (kJ/mol) 
________________________________________________ 
5a   253   416 
5b   254   419 
5c   254   420 
5d   252   410 
5e   243   411 
5f   246   408 
5g   243   409 
5h   247   431 
________________________________________________ 
 
 
Table 3. - Physical and analytical data for quinazolin-4-ones (6a-h).  
 
Compd Mp (°C) IR(nujol) 
ν (cm-1) 
1H NMR (TMS)  
δ (ppm) 
MS 
m/z (%) 
Molecular 
Formula 
Analysis 
Calcd (Found)
C/H/ N 
6a 245-248a      
6b 158-160b      
6c 178-180c      
6d 279-281d 3160, 1665 7.65-7.69 e (m, 1H, Ar), 7.77-7.80 (m, 
1H, Ar), 7.88-7.92 (m, 1H, Ar), 8.25-
8.29 (m, 1H, Ar), 
312 (M+, 100), 195 (15), 
124 (25), 117 (26), 90 (36), 
63 (55) 
C14H5N2OF5 53.86/1.61/8.97 
(53.80/1.50/8.80)
6e 312-313d 3172, 1680 7.63-7.82f (m, 3H. Ar), 8.13-8.34 (m, 
2H, Ar), 13.01 (br s, 1H, NH)g 
294 (M+, 34), 119 (32), 85 
(47), 71 (66), 57 (100) 
C14H6N2OF4 57.16/2.06/9.52 
(57.20/2.00/9.50)
6f 278-282d 3170, 1670 7.63-7.81f (m, 3H, Ar), 7.92-8.01 (m, 
1H, Ar) 8.13-8.41 (m, 2H, Ar), 12.90 
(br s, 1H, NH)g 
276 (M+, 100), 173 (72), 
144 (13), 104 (10), 77 (25) 
C14H7N2OF3 60.88/2.55/10.14
(60.70/2.40/10.10)
6g 238-242h 3160, 1690 2.42 f (s, 3H, Me), 12.69 (br s, 1H, 
NH)g 
232 (M+, 100), 214 (90), 
191 (25) 
C9H4N2OF4 46.57/1.74/12.07
(46.40/1.60/12.00)
6h 292-294d 3180, 1684 2.38 (s, 3H, Me) 7.52-7.60 (m, 1H, 
Ar) 12.52 (br s, 1H, NH)g 
214 (M+, 100), 173 (19), 
146 (15) 
C9H5N2OF3 50.48/2.35/13.08
(50.30/2.30/13.00)
a Lit., 15 mp 249-250 °C     e in acetone-d6. 
b Lit., 15 mp 160-161 °C     f in DMSO-d6. 
c Lit., 15 mp 181.5-182.5 °C     g exchangeable with D2O. 
d Crystallization solvent: Ethanol    h Crystallization solvent: Benzene. 
 
EXPERIMENTAL  
 
General: Melting points were determined on a REICHART-THERMOVAR hot-stage apparatus and are 
uncorrected. IR spectra (Nujol) were determined with a PERKIN ELMER 257 instrument; 1H-NMR 
spectra were recorded on a BRUKER AC 250 E spectrometer, and GC/MS determinations were carried 
out on a VARIAN STAR 3400 CX/SATURN 2000 system. Fluorescence emission spectra were 
determined in methanol using a JASCO FP-777WI spectrofluorimeter. Flash chromatography was 
performed by using silica gel (Merck, 0.040-0.063 mesh) and mixtures of ethyl acetate and light 
petroleum (fraction boiling in the range 40-60°C) in various ratios. Dry methanol and acetonitrile (from 
Romil Pure Chemicals) were used as received.  
Compounds (5a-c)6 and (5d)16 were prepared as reported; compounds (5e-h and 7) were prepared 
similarly to the reported procedure17 as described below. 
 
Synthesis of 5-polyfluoroaryl-1,2,4-oxadiazoles (5e-h, 7). General procedure. 
A mixture of benzamidoxime (for compound 5e,f and 7), or acetamidoxime (for compound 5g,h) (10 
mmol), pyridine (0.9 mL, 11 mmol) and the appropriate polyfluorobenzoyl chloride (11 mmol) was 
refluxed for 8 h in anhydrous toluene (100 mL). After removal of the solvent, the residue was treated with 
water and then extracted with EtOAc. The organic layers were dried over Na2SO4 and evaporated. 
Chromatography of the residue gave the oxadiazoles (5e-h and 7) (yields 60-80%). 
 
3-Phenyl-5-(2,3,4,5-tetrafluorophenyl)-1,2,4-oxadiazole (5e), had mp 150-151°C (ethanol), 1H NMR 
(CDCl3) δ 7.27-7.57 (m, 3H, Ar); 7.90-7.95 (m, 1H, Ar); 8.15-8.19 (m, 2H, Ar). MS m/z 294 (M+ , 100), 
177 (11), 119 (41). Anal. Calcd for C14H6N2OF4: C, 57.16; H, 2.06; N, 9.52. Found: C,57.10; H,2.00; N, 
9.40. 
 
3-Phenyl-5-(2,3,4-trifluorophenyl)-1,2,4-oxadiazole (5f), had mp 144-145°C (ethanol), 1H NMR 
(CDCl3) δ 7.14-7.27 (m, 1H, Ar); 7.50-7.56 (m, 3H, Ar); 7.96-8.05 (m, 1H, Ar); 8.15-8.19 (m, 2H, Ar). 
MS m/z 276 (M+ , 100), 119 (29), 64 (21).  Anal. Calcd for C14H7N2OF5: C, 57.16; H, 2.06; N, 9.52. 
Found: C,57.10; H,2.00; N, 9.40. 
 
3-Methyl-5-(2,3,4,5-tetrafluorophenyl)-1,2,4-oxadiazole (5g), had mp 150-151°C (ethanol), 1H NMR 
(CDCl3) δ 2.50 (s, 3H, Me); 7.72-7.77 (m, 1H, Ar);. MS m/z 232(M+ , 100), 175 (14), 58 (15). Anal. 
Calcd for C9H4N2OF4: C, 46.57; H, 1.74; N, 12.07. Found: C, 46.50; H,1.70; N, 12.00. 
 
3-Methyl-5-(2,3,4-trifluorophenyl)-1,2,4-oxadiazole (5h), had mp 72-73°C (light petroleum), 1H NMR 
(CDCl3) δ 2.51 (s, 3H, Me); 7.11-7.22 (m, 1H, Ar); 7.83-7.92 (m, 1H, Ar); MS m/z 214(M+ , 100), 157 
(12). Anal. Calcd for C9H5N2OF3: C, 50.48; H, 2.35; N, 13.08. Found: C, 50.50; H,2.30; N, 12.90. 
 
3-Phenyl-5-pentafluorophenyl-1,2,4-oxadiazole (7), had mp 132°C (ethanol); 1H-NMR (CDCl3) δ 7.53-
7.71 (m, 3H), 8.21-8.25 (m, 2H); MS m/z (312 M+ 100), 195 (25), 119 (81), 91 (46), 63 (54). 
C14H5N2OF5: C, 53.86; H, 1.61; N, 8.97. Found: C, 53.80; H,1.50; N, 8.90. 
General Procedure for Photochemical Reactions 
Photochemical reactions were carried out by using a Rayonet RPR-100 photoreactor fitted with 16 Hg 
lamps irradiating at λ= 313 nm (RPR 3000Å) and λ= 365 nm (RPR 3650Å) and equipped with a merry-
go-round apparatus. 
 
Irradiations at λ=313 nm in the presence of TEA. 
A solution of compounds (5a-h) (1.5 mmol) in anhydrous acetonitrile (150 ml), was partitioned into six 
pyrex tubes and purged with nitrogen (10 min). An excess of TEA (Molar ratio TEA/oxadiazole = 10/1) 
was added and all the samples were irradiated for 2 h (4 h for 5a-c). The solvent was evaporated to 
dryness under reduced pressure yielding a residue that was chromatographed with light petroleum/ethyl 
acetate at various ratios. Yields and spectroscopic data are respectively reported in Tables 1 and 3. 
 
Irradiations at λ=365 nm in the presence of Pyrene. 
A solution of compounds (5a-h) (1.5 mmol) in anhydrous methanol (for compounds 5a-c) or acetonitrile 
(for compounds 5d-h) (150 mL) containing pyrene as sensitizer (0.6 g, 3 mmol), was partitioned into six 
pyrex tubes, purged with nitrogen (10 min) and irradiated for 5 h. Yields and spectroscopic data are 
respectively reported in Tables 1 and 3 
 
Irradiations of compound 7 at λ=365 nm in the presence of pyrene. 
Irradiation of the compound (7) in acetonitrile in the presence of pyrene gave recovered starting material 
(50%) and N-pentafluorobenzoylbenzamidine (9) (20%). 
Compound (9) had mp 287-290 °C (ethanol), IR 3420, 3320, 3220, 1670 cm-1; 1H-NMR (DMSO-d6) δ 
7.55-7.72 (m, 3H), 7.90-8.15 (m, 2H), 9.93 (s, 1H), 10.30 (s, 1H); MS m/z (314 M+ 30), 195 (62),167 (66), 
147 (100), 117 (23), 104 ( 65), 77 (68), 63 (54). C14H7N2OF5: C, 53.52; H, 2.25; N, 8.92. Found: C, 
53.40; H,2.10; N, 8.80. 
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